Navigation Links
EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
Date:4/14/2008

New Drugs on the Horizon Session Highlights New Small Molecule Drug

Candidates

ROCKVILLE, Md., April 14 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical and mechanism of action data for its selective kinase inhibitor, ENMD-2076. On Sunday, April 13, 2008, Mark R. Bray, Ph.D., Vice President, Research, gave an oral presentation during the "New Drugs on the Horizon 2" symposium at the American Association for Cancer Research (AACR) Annual Meeting being held this week in San Diego, California.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

During the presentation, Dr. Bray highlighted ENMD-2076's unique combination of antiangiogenic, cell cycle, and antiproliferative activities. In preclinical studies, ENMD-2076 demonstrated potent activity against Aurora A and tyrosine kinases linked to promoting cancer and inflammatory diseases. ENMD-2076 acts through multiple pathways resulting in antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated substantial, dose-dependent efficacy as a single agent in multiple xenograft models, including tumor regression in breast, colon, and leukemia models. ENMD-2076 is an orally active, multi-kinase inhibitor that has shown an acceptable toxicity profile in multiple preclinical studies without cardiovascular effects.

Dr. Bray commented on the presentation, "We are fortunate to have been selected to showcase the potent activity of ENMD-2076 during t
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
2. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
3. New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
4. Kosans Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
5. Study Shows Coronado Biosciences Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
6. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
7. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
10. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
11. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., NEW YORK, Nov. 9 "Micro cap and...ng to receive more broker sponsorship and exposure...of the upturn in commodity-driven stocks like gold...resident of The Haft Group, Inc, Manhattan based i...ap and small cap equities market in the US and Can...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 NexBio, Inc. ... annual American College of Allergy, Asthma, and I... entitled "DAS181 (Fludase®), a Sialidase, De...ammatory Effects in Animal Models of Asthma". ,...road spectrum host-targeting drug candidate being ...
(Date:11/8/2009)...ovember 6, 2009 As global temperatures and energy...gy will be key to a sustainable future. An attra...two studies published online in Genome Research ...enome structures of bioethanol-producing microorga...cal in developing new technologies needed to imple...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ ...heets: HXBPF) today announced that John Docherty, ...t at Merriman Curhan Ford,s 6th annual Investor Su...l Hotel in New York City. Mr. Docherty will provi...velopment programs L-DOS47 and Topical Interferon ...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3
...witzerland, August 25 Mymetics,Corporation (OTCBB...n will,be made available via Standard & Poor,s Mar...rvice that enables subscribing publicly traded,com...ted to users of,Standard & Poor,s Advisor Insight....ugh this program includes share price, volume, div...
...s Stephen Ross Senior Vice President of Commercial... of Human Resources, CLINTON, N.J., Aug. 25 Ikar...e biotherapeutics company, announced today the,add...ppointed Senior Vice,President of Commercial Opera...dent for Human Relations., Daniel Tasse, Presiden...
...witzerland, August 25 Mymetics,Corporation (OTC: ...l on,Wednesday August 27th 2008 at 1 PM New York T...ess of the company, the June 30th 2008 Form 10-Q a...n the call Toll Free from the US at +1-866-591-436...IN 815 726., Corporate description:, Mymetics, p...
Other Biology Technology:Mymetics Corporation Information to be Available Through Standard & Poor's Market Access Program 2Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership 2
(Date:11/6/2009)...nth of the publication of On the Origin of Species...IBS) is publishing open access two peer-reviewed a...ghts into evolution. , The two articles are by Ke...ey, and James T. Costa of Western Carolina Univers...rwin," appeared in the October issue of the AIBS j...
(Date:11/6/2009)... Hills, MI-based Law Enforcement Intelligent Devic...m and patent-pending Biometric Access Control Syst... Human Services, National Institutes of Health (NI...support the NIH,s entire police force that is resp...ch agency. The project is expected to be complete...
(Date:11/5/2009)...rs (NABT) will recognize Leonard C. Yannielli, pro...Community College (NVCC) in Waterbury, Connecticut...he NABT annual professional development conference...o. , The Evolution Education Award is cosponsore...,(AIBS) and Biological Sciences Curriculum Study ...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Survivors of Childhood Cancer Less Likely to Marry 59113 1Survivors of Childhood Cancer Less Likely to Marry 59113 2Survivors of Childhood Cancer Less Likely to Marry 59113 3Survivors of Childhood Cancer Less Likely to Marry 59113 4High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 1High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 2High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 3High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 4Two Hutchinson Center Scientists Receive a Total of 2416 7 Million for Collaborative Stem Cell Research 5313 1Two Hutchinson Center Scientists Receive a Total of 2416 7 Million for Collaborative Stem Cell Research 5313 2
...studying fuels from biomass for years. Now, with g...nscious society emerging, biofuels are fast becomi...s all across America. , Ethanol blends are alrea...availability varies from state to state, depending...mass for biofuel production in each state also var...
... United Nations called for a Green Revolution in A... promise of fighting hunger in Africa through agri... agriculture, nutrition, environment, markets and ...e African Green Revolution Takes Shape, on Tuesday...rnest N. Morial Convention Center in New Orleans. ...
...cane Katrina devastated New Orleans and parts of t...aders will share lessons learned during the Intern... Agronomy (ASA), Crop Science Society of America (...Nov. 7-8 at the Ernest N. Morial Convention Center...r and Sustainable Coastal Development: An Integrat...
Other Biology News:The race for biofuels driving alternative sources of biomass 2Now is Africa's turn for a green revolution, global experts say 2Soil, conservation experts to reflect on Hurricane Katrina disaster 2
...IRsolution software provides quick and easy operat...-based control. The software is fully secure and ...lations, and compatible with user-created macros f...nables use in high-level research and development ...
Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
...The PerkinElmer kit provides reagents for immune c...xes in serum and plasma samples using a combinatio...ized and transferred to microplate wells which are...tibody to HIV-1 p24. The immobilized monoclonal an...
Mitochondria Isolation Kit for Tissue and Cultured Cells from BioChain
Biology Products: